A detailed history of Two Sigma Securities, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Two Sigma Securities, LLC holds 16,200 shares of BNTX stock, worth $1.85 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,200
Previous 9,200 76.09%
Holding current value
$1.85 Million
Previous $739,000 160.35%
% of portfolio
0.03%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$78.36 - $124.66 $3.77 Million - $6 Million
48,163 Added 1352.13%
51,725 $6.14 Million
Q2 2024

Aug 14, 2024

BUY
$80.36 - $102.87 $286,242 - $366,422
3,562 New
3,562 $286,000
Q4 2023

Feb 14, 2024

BUY
$90.91 - $112.75 $75,182 - $93,244
827 Added 42.09%
2,792 $294,000
Q3 2023

Nov 14, 2023

SELL
$98.5 - $125.08 $341,204 - $433,277
-3,464 Reduced 63.81%
1,965 $213,000
Q2 2023

Aug 14, 2023

SELL
$102.58 - $129.66 $432,579 - $546,776
-4,217 Reduced 43.72%
5,429 $585,000
Q1 2023

May 15, 2023

BUY
$122.57 - $153.67 $1.18 Million - $1.48 Million
9,646 New
9,646 $1.2 Million
Q3 2022

Nov 14, 2022

BUY
$127.65 - $183.11 $596,380 - $855,489
4,672 New
4,672 $630,000
Q1 2022

May 16, 2022

BUY
$126.25 - $231.85 $346,051 - $635,500
2,741 Added 151.77%
4,547 $776,000
Q4 2021

Feb 14, 2022

BUY
$216.64 - $362.52 $391,251 - $654,711
1,806 New
1,806 $466,000
Q1 2021

May 17, 2021

SELL
$85.73 - $119.5 $343,948 - $479,434
-4,012 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$72.71 - $129.54 $291,712 - $519,714
4,012 New
4,012 $327,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.7B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.